nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.0353	0.519	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00361	0.0532	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—AKT1—peripheral nervous system neoplasm	0.00361	0.0531	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00238	0.0351	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00194	0.00209	CcSEcCtD
Gentamicin—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00194	0.00209	CcSEcCtD
Gentamicin—Stomatitis—Cisplatin—peripheral nervous system neoplasm	0.00194	0.00208	CcSEcCtD
Gentamicin—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.00194	0.00208	CcSEcCtD
Gentamicin—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00193	0.00207	CcSEcCtD
Gentamicin—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00193	0.00207	CcSEcCtD
Gentamicin—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.0019	0.00204	CcSEcCtD
Gentamicin—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.00186	0.00199	CcSEcCtD
Gentamicin—Hypocalcaemia—Doxorubicin—peripheral nervous system neoplasm	0.00185	0.00198	CcSEcCtD
Gentamicin—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00184	0.00197	CcSEcCtD
Gentamicin—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00184	0.00197	CcSEcCtD
Gentamicin—Oliguria—Doxorubicin—peripheral nervous system neoplasm	0.00184	0.00197	CcSEcCtD
Gentamicin—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00183	0.00196	CcSEcCtD
Gentamicin—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00182	0.00196	CcSEcCtD
Gentamicin—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00182	0.00195	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00181	0.00194	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00179	0.00192	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00179	0.00192	CcSEcCtD
Gentamicin—Neuropathy peripheral—Etoposide—peripheral nervous system neoplasm	0.00179	0.00192	CcSEcCtD
Gentamicin—Alopecia—Vincristine—peripheral nervous system neoplasm	0.00179	0.00192	CcSEcCtD
Gentamicin—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00178	0.00191	CcSEcCtD
Gentamicin—Stomatitis—Etoposide—peripheral nervous system neoplasm	0.00178	0.00191	CcSEcCtD
Gentamicin—Salivary hypersecretion—Epirubicin—peripheral nervous system neoplasm	0.00178	0.00191	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00177	0.0019	CcSEcCtD
Gentamicin—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00177	0.0019	CcSEcCtD
Gentamicin—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00177	0.0019	CcSEcCtD
Gentamicin—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00177	0.00189	CcSEcCtD
Gentamicin—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00175	0.00187	CcSEcCtD
Gentamicin—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00173	0.00185	CcSEcCtD
Gentamicin—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.00172	0.00185	CcSEcCtD
Gentamicin—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00171	0.00184	CcSEcCtD
Gentamicin—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00171	0.00184	CcSEcCtD
Gentamicin—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.0017	0.00183	CcSEcCtD
Gentamicin—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.00181	CcSEcCtD
Gentamicin—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00169	0.00181	CcSEcCtD
Gentamicin—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00167	0.00179	CcSEcCtD
Gentamicin—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.00164	0.00176	CcSEcCtD
Gentamicin—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00164	0.00175	CcSEcCtD
Gentamicin—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.00163	0.00175	CcSEcCtD
Gentamicin—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00163	0.00175	CcSEcCtD
Gentamicin—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00162	0.00174	CcSEcCtD
Gentamicin—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00162	0.00174	CcSEcCtD
Gentamicin—LRP2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00161	0.0237	CbGpPWpGaD
Gentamicin—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00158	0.0017	CcSEcCtD
Gentamicin—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00158	0.0017	CcSEcCtD
Gentamicin—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.00158	0.0017	CcSEcCtD
Gentamicin—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00158	0.00169	CcSEcCtD
Gentamicin—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00158	0.00169	CcSEcCtD
Gentamicin—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00158	0.00169	CcSEcCtD
Gentamicin—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00158	0.00169	CcSEcCtD
Gentamicin—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00157	0.00168	CcSEcCtD
Gentamicin—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00168	CcSEcCtD
Gentamicin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00168	CcSEcCtD
Gentamicin—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00156	0.00167	CcSEcCtD
Gentamicin—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00156	0.00167	CcSEcCtD
Gentamicin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00167	CcSEcCtD
Gentamicin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00167	CcSEcCtD
Gentamicin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00154	0.00166	CcSEcCtD
Gentamicin—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.00154	0.00165	CcSEcCtD
Gentamicin—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00153	0.00164	CcSEcCtD
Gentamicin—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00152	0.00163	CcSEcCtD
Gentamicin—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.0015	0.00161	CcSEcCtD
Gentamicin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00149	0.0016	CcSEcCtD
Gentamicin—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.00149	0.00159	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00147	0.00157	CcSEcCtD
Gentamicin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00146	0.00157	CcSEcCtD
Gentamicin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.00157	CcSEcCtD
Gentamicin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00145	0.00156	CcSEcCtD
Gentamicin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00145	0.00156	CcSEcCtD
Gentamicin—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00145	0.00155	CcSEcCtD
Gentamicin—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00144	0.00154	CcSEcCtD
Gentamicin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00144	0.00154	CcSEcCtD
Gentamicin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00143	0.00154	CcSEcCtD
Gentamicin—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00143	0.00153	CcSEcCtD
Gentamicin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00141	0.00151	CcSEcCtD
Gentamicin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.0014	0.00151	CcSEcCtD
Gentamicin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.0014	0.0015	CcSEcCtD
Gentamicin—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00139	0.0015	CcSEcCtD
Gentamicin—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.0015	CcSEcCtD
Gentamicin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00139	0.00149	CcSEcCtD
Gentamicin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00139	0.00149	CcSEcCtD
Gentamicin—LRP2—Disease—GNS—peripheral nervous system neoplasm	0.00139	0.0204	CbGpPWpGaD
Gentamicin—Purpura—Epirubicin—peripheral nervous system neoplasm	0.00138	0.00148	CcSEcCtD
Gentamicin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00138	0.00148	CcSEcCtD
Gentamicin—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00147	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00147	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00146	CcSEcCtD
Gentamicin—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00145	CcSEcCtD
Gentamicin—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00145	CcSEcCtD
Gentamicin—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00134	0.00144	CcSEcCtD
Gentamicin—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.00144	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.00134	0.0197	CbGpPWpGaD
Gentamicin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00133	0.00142	CcSEcCtD
Gentamicin—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00132	0.00142	CcSEcCtD
Gentamicin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00131	0.00141	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00131	0.00141	CcSEcCtD
Gentamicin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.0013	0.0014	CcSEcCtD
Gentamicin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.0013	0.0014	CcSEcCtD
Gentamicin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00139	CcSEcCtD
Gentamicin—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00129	0.00139	CcSEcCtD
Gentamicin—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00128	0.00138	CcSEcCtD
Gentamicin—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00128	0.00137	CcSEcCtD
Gentamicin—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.00128	0.00137	CcSEcCtD
Gentamicin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00127	0.00137	CcSEcCtD
Gentamicin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00127	0.00136	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00136	CcSEcCtD
Gentamicin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00126	0.00135	CcSEcCtD
Gentamicin—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00135	CcSEcCtD
Gentamicin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00134	CcSEcCtD
Gentamicin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00134	CcSEcCtD
Gentamicin—Rash—Topotecan—peripheral nervous system neoplasm	0.00125	0.00134	CcSEcCtD
Gentamicin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00125	0.00134	CcSEcCtD
Gentamicin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00125	0.00134	CcSEcCtD
Gentamicin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00134	CcSEcCtD
Gentamicin—Headache—Topotecan—peripheral nervous system neoplasm	0.00124	0.00133	CcSEcCtD
Gentamicin—Rash—Tretinoin—peripheral nervous system neoplasm	0.00124	0.00133	CcSEcCtD
Gentamicin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00124	0.00133	CcSEcCtD
Gentamicin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00124	0.00133	CcSEcCtD
Gentamicin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00124	0.00133	CcSEcCtD
Gentamicin—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00124	0.00133	CcSEcCtD
Gentamicin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00124	0.00133	CcSEcCtD
Gentamicin—Headache—Tretinoin—peripheral nervous system neoplasm	0.00123	0.00132	CcSEcCtD
Gentamicin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00123	0.00132	CcSEcCtD
Gentamicin—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00123	0.00132	CcSEcCtD
Gentamicin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.00132	CcSEcCtD
Gentamicin—Rash—Melphalan—peripheral nervous system neoplasm	0.00123	0.00131	CcSEcCtD
Gentamicin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00122	0.00131	CcSEcCtD
Gentamicin—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00121	0.0013	CcSEcCtD
Gentamicin—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00127	CcSEcCtD
Gentamicin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00119	0.00127	CcSEcCtD
Gentamicin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00127	CcSEcCtD
Gentamicin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00127	CcSEcCtD
Gentamicin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00118	0.00126	CcSEcCtD
Gentamicin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00117	0.00126	CcSEcCtD
Gentamicin—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.00117	0.00126	CcSEcCtD
Gentamicin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00125	CcSEcCtD
Gentamicin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00125	CcSEcCtD
Gentamicin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00116	0.00125	CcSEcCtD
Gentamicin—LRP2—Metabolism—GNS—peripheral nervous system neoplasm	0.00116	0.0171	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00124	CcSEcCtD
Gentamicin—Nausea—Melphalan—peripheral nervous system neoplasm	0.00115	0.00124	CcSEcCtD
Gentamicin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00114	0.00122	CcSEcCtD
Gentamicin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00114	0.00122	CcSEcCtD
Gentamicin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00122	CcSEcCtD
Gentamicin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00114	0.00122	CcSEcCtD
Gentamicin—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.0012	CcSEcCtD
Gentamicin—LRP2—Metabolism—NME1—peripheral nervous system neoplasm	0.00112	0.0164	CbGpPWpGaD
Gentamicin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00119	CcSEcCtD
Gentamicin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00118	CcSEcCtD
Gentamicin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00109	0.00117	CcSEcCtD
Gentamicin—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00116	CcSEcCtD
Gentamicin—LRP2—Metabolism—COX2—peripheral nervous system neoplasm	0.00107	0.0158	CbGpPWpGaD
Gentamicin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00106	0.00114	CcSEcCtD
Gentamicin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00106	0.00113	CcSEcCtD
Gentamicin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00113	CcSEcCtD
Gentamicin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00105	0.00112	CcSEcCtD
Gentamicin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00105	0.00112	CcSEcCtD
Gentamicin—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00111	CcSEcCtD
Gentamicin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.0011	CcSEcCtD
Gentamicin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00101	0.00109	CcSEcCtD
Gentamicin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00101	0.00109	CcSEcCtD
Gentamicin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00108	CcSEcCtD
Gentamicin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.001	0.00108	CcSEcCtD
Gentamicin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000998	0.00107	CcSEcCtD
Gentamicin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000987	0.00106	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000973	0.0143	CbGpPWpGaD
Gentamicin—LRP2—Disease—PPP3R1—peripheral nervous system neoplasm	0.000972	0.0143	CbGpPWpGaD
Gentamicin—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000961	0.00103	CcSEcCtD
Gentamicin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00096	0.00103	CcSEcCtD
Gentamicin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000956	0.00103	CcSEcCtD
Gentamicin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000955	0.00103	CcSEcCtD
Gentamicin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000951	0.00102	CcSEcCtD
Gentamicin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000949	0.00102	CcSEcCtD
Gentamicin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000941	0.00101	CcSEcCtD
Gentamicin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00094	0.00101	CcSEcCtD
Gentamicin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000937	0.00101	CcSEcCtD
Gentamicin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000935	0.001	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000933	0.0137	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000929	0.000996	CcSEcCtD
Gentamicin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000925	0.000993	CcSEcCtD
Gentamicin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000923	0.000991	CcSEcCtD
Gentamicin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000921	0.000988	CcSEcCtD
Gentamicin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000914	0.000981	CcSEcCtD
Gentamicin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000914	0.000981	CcSEcCtD
Gentamicin—Rash—Vincristine—peripheral nervous system neoplasm	0.000907	0.000973	CcSEcCtD
Gentamicin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000906	0.000972	CcSEcCtD
Gentamicin—Headache—Vincristine—peripheral nervous system neoplasm	0.000901	0.000967	CcSEcCtD
Gentamicin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000886	0.000951	CcSEcCtD
Gentamicin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000886	0.00095	CcSEcCtD
Gentamicin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000884	0.000948	CcSEcCtD
Gentamicin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000858	0.000921	CcSEcCtD
Gentamicin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000857	0.000919	CcSEcCtD
Gentamicin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000854	0.000916	CcSEcCtD
Gentamicin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000846	0.000908	CcSEcCtD
Gentamicin—LRP2—Disease—ENO2—peripheral nervous system neoplasm	0.000842	0.0124	CbGpPWpGaD
Gentamicin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000824	0.000884	CcSEcCtD
Gentamicin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000819	0.000879	CcSEcCtD
Gentamicin—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000812	0.000871	CcSEcCtD
Gentamicin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000808	0.000867	CcSEcCtD
Gentamicin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000802	0.00086	CcSEcCtD
Gentamicin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000801	0.000859	CcSEcCtD
Gentamicin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.0008	0.000858	CcSEcCtD
Gentamicin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000793	0.000851	CcSEcCtD
Gentamicin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00077	0.000826	CcSEcCtD
Gentamicin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000755	0.00081	CcSEcCtD
Gentamicin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000751	0.000806	CcSEcCtD
Gentamicin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000741	0.000795	CcSEcCtD
Gentamicin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00074	0.000794	CcSEcCtD
Gentamicin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000739	0.000793	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000737	0.0108	CbGpPWpGaD
Gentamicin—Rash—Etoposide—peripheral nervous system neoplasm	0.000734	0.000788	CcSEcCtD
Gentamicin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000734	0.000787	CcSEcCtD
Gentamicin—Headache—Etoposide—peripheral nervous system neoplasm	0.00073	0.000783	CcSEcCtD
Gentamicin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000719	0.000771	CcSEcCtD
Gentamicin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000716	0.000768	CcSEcCtD
Gentamicin—LRP2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000705	0.0104	CbGpPWpGaD
Gentamicin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000693	0.000744	CcSEcCtD
Gentamicin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000692	0.000742	CcSEcCtD
Gentamicin—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000691	0.000741	CcSEcCtD
Gentamicin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000684	0.000734	CcSEcCtD
Gentamicin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000681	0.000731	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000681	0.01	CbGpPWpGaD
Gentamicin—LRP2—Disease—SLC2A1—peripheral nervous system neoplasm	0.000679	0.00998	CbGpPWpGaD
Gentamicin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000665	0.000714	CcSEcCtD
Gentamicin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000663	0.000711	CcSEcCtD
Gentamicin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000658	0.000706	CcSEcCtD
Gentamicin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000653	0.000701	CcSEcCtD
Gentamicin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000641	0.000688	CcSEcCtD
Gentamicin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000639	0.000686	CcSEcCtD
Gentamicin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000639	0.000686	CcSEcCtD
Gentamicin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00063	0.000676	CcSEcCtD
Gentamicin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00061	0.000655	CcSEcCtD
Gentamicin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000609	0.000654	CcSEcCtD
Gentamicin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000604	0.000648	CcSEcCtD
Gentamicin—LRP2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000596	0.00876	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000638	CcSEcCtD
Gentamicin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000592	0.000635	CcSEcCtD
Gentamicin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000586	0.000629	CcSEcCtD
Gentamicin—LRP2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000568	0.00836	CbGpPWpGaD
Gentamicin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000568	0.000609	CcSEcCtD
Gentamicin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000565	0.000606	CcSEcCtD
Gentamicin—LRP2—Metabolism—TH—peripheral nervous system neoplasm	0.00056	0.00824	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.000591	CcSEcCtD
Gentamicin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000542	0.000582	CcSEcCtD
Gentamicin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000538	0.000577	CcSEcCtD
Gentamicin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.000563	CcSEcCtD
Gentamicin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000519	0.000557	CcSEcCtD
Gentamicin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000554	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000511	0.00752	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000501	0.00738	CbGpPWpGaD
Gentamicin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.000534	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000481	0.00708	CbGpPWpGaD
Gentamicin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000516	CcSEcCtD
Gentamicin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.000515	CcSEcCtD
Gentamicin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.000512	CcSEcCtD
Gentamicin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000462	0.000496	CcSEcCtD
Gentamicin—LRP2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000457	0.00673	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000449	0.0066	CbGpPWpGaD
Gentamicin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000478	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000437	0.00643	CbGpPWpGaD
Gentamicin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000432	0.000463	CcSEcCtD
Gentamicin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000459	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000417	0.00613	CbGpPWpGaD
Gentamicin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000445	CcSEcCtD
Gentamicin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000412	0.000442	CcSEcCtD
Gentamicin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000411	0.000441	CcSEcCtD
Gentamicin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000409	0.000439	CcSEcCtD
Gentamicin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.000429	CcSEcCtD
Gentamicin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000416	CcSEcCtD
Gentamicin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.000412	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000382	0.00562	CbGpPWpGaD
Gentamicin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.000409	CcSEcCtD
Gentamicin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.000408	CcSEcCtD
Gentamicin—LRP2—Disease—PTPN11—peripheral nervous system neoplasm	0.000379	0.00558	CbGpPWpGaD
Gentamicin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000406	CcSEcCtD
Gentamicin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000385	CcSEcCtD
Gentamicin—LRP2—Disease—ERBB2—peripheral nervous system neoplasm	0.0003	0.00441	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000266	0.00391	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000255	0.00375	CbGpPWpGaD
Gentamicin—LRP2—Disease—NRAS—peripheral nervous system neoplasm	0.000228	0.00336	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYC—peripheral nervous system neoplasm	0.000213	0.00313	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.00021	0.00309	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000205	0.00302	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000201	0.00296	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000191	0.0028	CbGpPWpGaD
Gentamicin—LRP2—Disease—HRAS—peripheral nervous system neoplasm	0.000167	0.00246	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00016	0.00235	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000149	0.00219	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT1—peripheral nervous system neoplasm	0.000147	0.00217	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKT1—peripheral nervous system neoplasm	0.000123	0.00182	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000122	0.0018	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000117	0.00172	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000103	0.00152	CbGpPWpGaD
